- Home
- IHRT vs NGEN Comparison
IHRT vs NGEN Comparison
Compare IHRT & NGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | IHRT | NGEN |
|---|---|---|
| Founded | 1974 | 2017 |
| Country | United States | Canada |
| Employees | 9550 | 14 |
| Industry | Broadcasting | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 388.7M | 337.4M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | IHRT | NGEN |
|---|---|---|
| Price | $5.23 | $3.75 |
| Analyst Decision | Sell | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | $4.25 | ★ $18.00 |
| AVG Volume (30 Days) | ★ 769.4K | 239.4K |
| Earning Date | 05-11-2026 | 04-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $9.96 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.01 | $3.51 |
| 52 Week High | $6.15 | $5.93 |
Technical Indicators
Market Signals| Indicator | IHRT | NGEN |
|---|---|---|
| Relative Strength Index (RSI) | 80.20 | 39.86 |
| Support Level | $2.59 | $3.65 |
| Resistance Level | $5.44 | $4.44 |
| Average True Range (ATR) | 0.36 | 0.21 |
| MACD | 0.15 | -0.03 |
| Stochastic Oscillator | 67.53 | 16.00 |
Price Performance
Historical ComparisonAbout IHRT iHeartMedia Inc.
iHeartMedia Inc is a United States-based audio media company. The company operates through the segments of the Multiplatform Group, the Digital Audio Group, and the Audio & Media Services Group. The company derives prime revenue from the Multiplatform Group segment which includes the company's Broadcast radio, Networks and Sponsorships, and Events businesses. The Digital Audio Group segment includes all of the company's digital businesses, including podcasting; and the Audio & Media Services Group includes Katz Media Group, a full-service media representation business, and RCS Sound Software, a provider of scheduling and broadcast software and services.
About NGEN NervGen Pharma Corp. Common stock
NervGen Pharma Corp is a clinical-stage biotech company. The company's principal business activity is the discovery, development, and commercialization of pharmaceutical treatments that enable the nervous system to repair itself following damage, whether due to injury or disease. The company's initial target indication is spinal cord injury. The company's pipeline products include NVG-291 and NVG-300.